Teriflunomide Tablet, Film Coated
NDC Package 12579-191-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Teriflunomide tablets is a medication used to treat multiple sclerosis-MS. This formulation utilizes a tablet, film coated delivery system. Marketed by Opella Healthcare International Sas, this product is identified by NDC 12579-191.

Identification & Billing

NDC Package Code
12579-191-00
Package Description
200000 TABLET, FILM COATED in 1 DRUM
Product Code
12579-191
11-Digit Billing Format
12579019100

Clinical Specifications

Proprietary Name
Teriflunomide
Non-Proprietary Name
Teriflunomide
Substance Name
Teriflunomide
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Active Ingredient(s)
TERIFLUNOMIDE 14 mg/1
Usage Information
This medication is used to treat multiple sclerosis-MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS.

Regulatory & Marketing

Labeler Name
Opella Healthcare International Sas
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
05-01-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 12579-191-00 identifies a specific commercial package of 200000 tablet, film coated in 1 drum of Teriflunomide (UNFINISHED drug), drug for further processing labeled by Opella Healthcare International Sas. This tablet, film coated is formulated for use and contains teriflunomide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Opella Healthcare International Sas on May 01, 2013. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat multiple sclerosis-MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS.

How is this Opella Healthcare International Sas product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 12579019100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
12579-191-00
11-Digit CMS (5-4-2)
12579-0191-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.